AI/ML Platform Integration with Experimental Workflows
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract focuses on integrating AI-driven molecular design systems with experimental validation workflows to create a seamless, iterative drug discovery process. The goal is to leverage machine learning and artificial intelligence technologies to enhance the accuracy and efficiency of drug development by incorporating real-time experimental feedback into the design cycle. This integration aims to accelerate drug discovery timelines and improve the success rates of identifying viable drug candidates. The opportunity is issued as a subcontract under the NAICS code 541715 and is managed by the ASPR (Administration for Strategic Preparedness and Response) within the Department of Health and Human Services. The solicitation was posted on May 19, 2026, with a response deadline of July 17, 2026. While specific location details and points of contact are not provided, the contract underscores a strategic effort to advance computational and experimental convergence in pharmaceutical research through advanced AI/ML platforms.
General Info
Agency
NAICS
Place of Performance
DCSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
